Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Neptune Wellness Solutions Inc. (NEPT)

2.6   0.11 (4.42%) 11-19 14:00
Open: 2.49 Pre. Close: 2.49
High: 2.63 Low: 2.47
Volume: 591,639 Market Cap: 243M
Neptune Technologies & Bioressources Inc is a nutrition products company engaged in customizing nutrition solutions, specialty ingredients and consumer brands. It offers premium krill oil under OCEANO3 and other ingredients such as marine and seed oils.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.703 - 2.717 2.717 - 2.73
Low: 2.424 - 2.439 2.439 - 2.454
Close: 2.461 - 2.486 2.486 - 2.51

Technical analysis

as of: 2019-11-19 1:29:30 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.78     One year: 4.33
Support: Support1: 2.46    Support2: 2.05
Resistance: Resistance1: 3.23    Resistance2: 3.71
Pivot: 3.12
Moving Average: MA(5): 2.68     MA(20): 3.22
MA(100): 4.19     MA(250): 3.84
MACD: MACD(12,26): -0.26     Signal(9): -0.19
Stochastic oscillator: %K(14,3): 8.20     %D(3): 7.93
RSI: RSI(14): 33.08
52-week: High: 6.57  Low: 2.42  Change(%): -16.6
Average Vol(K): 3-Month: 66464  10-Days: 94957

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NEPT has closed above bottom band by 12.2%. Bollinger Bands are 32.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-11-15
The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization
Two-thirds of Americans say the use of marijuana should be legal, reflecting a considerable surge over the past decade.. Two-thirds of Americans say the use of marijuana should be legal, reflecting a steady increase over the past decade https://t.co/QoMXjiaUYk pic.twitter.com/V4vLqY3r9f — Pew Research Fact Tank (@FactTank) November 14, 2019 GW Pharmaceuticals PLC (NASDAQ: GWPH ) announced two of its medicines have been recommended by the U.K.’s National Institute for Health and Care Excellence to receive routine reimbursement from the National Health Service. Epidiolex, known as Epidyolex in Europe, and Sativex were approved by the NHS for the treatment of epilepsy and multiple sclerosis, respectively. These were probably the most upbeat news items in the cannabis and hemp world this week. The following companies disappointed analysts and investors with their quarterly results and/or guidance (see full coverage for all of these earnings reports in our Cannabis Earnings Portal ): Canopy Growth Corp (NYSE: CGC ) Neptune Wellness Solutions Inc.

2019-11-11
Neptune Wellness Falls On Higher Quarterly Net Loss, Announces Hemp-Derived CBD Deal
Neptune Wellness Solutions Inc. (NASDAQ: NEPT ) (TSX: NEPT) reported second-quarter revenue of CA$6.51 million ($4.9 million) on Monday and announced a partnership with International Flavors & Fragrances Inc. (NYSE: IFF ). The second-quarter revenue of CA$6.51 million was lower than the CA$7.07 million in revenue posted in the same period of 2018. The company also posted a quarterly net loss of CA$20.78 million versus a net loss of CA$3.05 million in the corresponding quarter of the prior year. Its adjusted EBITDA was a loss of CA$4.58 million, which is by CA$3.35 million lower than in the second quarter of 2018. Neptune also noted recent milestones such as the acquisition of SugarLeaf assets, which included the CBD consumer brand Forest Remedies; and its entrance into a strategic partnership … Full story available on Benzinga.com

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 93.60
Shares Float (M) 64.28
% Held by Insiders 18.84
% Held by Institutions 17.35
Shares Short (K) 7660
Shares Short P. Month (K)

Stock Financials

EPS -0.068
Book Value (p.s.) 0.800
PEG Ratio
Profit Margin -187.51
Operating Margin
Return on Assets (ttm) -10.0
Return on Equity (ttm) -38.7
Qtrly Rev. Growth -7.9
Gross Profit (p.s.) 0.081
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -38.01
P/E Growth Ratio 0.04
P/BV 3.23
P/S
P/CF

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2008-07-24
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.